Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-936104

ABSTRACT

With the increasing detection rate of early upper gastric cancer and adenocarcinoma of esophagogastric junction, the safety of proximal gastrectomy with clear indications has been verified, and function-preserving proximal gastrectomy has been widely used. However, proximal gastrectomy destructs the normal anatomical structure of esophagogastric junction, resulting in severe postoperative gastroesophageal reflux symptoms and seriously affecting the quality of life. Among various anti-reflux surgery methods, reconstruction of "cardiac valve" has always been the focus of relevant scholars because its similarity with the mechanism of normal anti-reflux. After years of development, evolution and optimization, the designed seromuscular flap anastomosis includes tunnel muscle flap anastomosis, Hatafuku valvuloplasty, single muscle flap anastomosis and double muscle flap anastomosis. The double muscle flap anastomosis has become a research hotspot because it shows good anti-reflux effect in clinical application. This paper reviews the history, research status and hot issues of seromuscular flap anastomosis of esophageal remnant stomach at home and abroad.


Subject(s)
Humans , Anastomosis, Surgical/methods , Esophagogastric Junction/surgery , Gastrectomy/methods , Gastroesophageal Reflux/surgery , Quality of Life , Stomach Neoplasms/surgery
2.
Preprint in English | medRxiv | ID: ppmedrxiv-20023333

ABSTRACT

BackgroundSince December 2019, pneumonia associated with the 2019 novel coronavirus (2019-nCoV) has emerged in Wuhan, China. The exponential increase of the confirmed number of cases of 2019n-CoV is of great concern to the global community. The fears and panic among residents in the epicenters have prompted diverse responses, which are understudied. During such a crisis, community trust and support for the government and health authorities are important to contain the outbreak. We aimed to investigate the influence of institutional trust on public responses to the 2019-nCoV outbreak. MethodsAn anonymous Internet-based, cross-sectional survey was administered on January 29, 2020. The study population comprised all residents currently residing or working in the province of Hubei, where Wuhan is the capital city. The level of trust in information provision and preventive instructions, individual preventive behaviors and treatment-seeking behaviors were queried. FindingsThe majority of the participants expressed a great extent of trust in the information and preventive instructions provided by the central government than by the local government. A high uptake of 2019-nCoV preventive measures was found, particularly among people who had been placed under quarantine. Being under quarantine (adjusted odds ratio [OR] = 2.35, 95% confidence interval [CI] 1.80 to 3.08) and having a high institutional trust score (OR = 2.23, 95% CI 1.96 to 2.53) were both strong and significant determinants of higher preventive behavior scores. The majority of study participants (85.7%, n = 3,640) reported that they would seek hospital treatment if they suspected themselves to have been infected with 2019 n-CoV. Few of the participants from Wuhan (16.6%, n = 475) and those participants who were under quarantine (13.8%, n = 550) expressed an unwillingness to seek hospital treatment. Similarly, being under quarantine (OR = 2.36, 95% CI 1.80 to 3.09) and having a high institutional trust score (OR = 2.20, 95% CI 1.96 to 2.49) were two strong significant determinants of hospital treatment-seeking. InterpretationThe results of this study suggest that institutional trust is an important factor influencing adequate preventive behavior and seeking formal medical care during an outbreak. In view of the 2019-nCoV being highly pathogenic and extremely contagious, our findings also underscore the importance of public health intervention to reach individuals with poor adherence to preventive measures and who are reluctant to seek treatment at formal health services. FundingNational Key R&D Program of China, Ningbo Health Branding Subject F und, Sanming Project of Medicine in Shenzhen, K.C. Wong Magna Fund in Ningbo University, National Natural Science Foundation of China, Fundamental Research Fu nds for the Central Universities, China Postdoctoral Science Foundation, and Natural Science Basic Research Program of Shanxi Province. Evidence before this studyWe searched PubMed on January 28, 2020, for articles that describe the trust, preventive practices and health-seeking behaviors related to the 2019 novel coronavirus (2019-nCoV) in China, using the search terms "novel coronavirus," "institutional trust," "behavioral change," "protective behaviors," and "treatment-seeking" with no language or publication time restrictions. Previously published research discussed the behavioral responses to the severe acute respiratory syndrome (SARS) epidemic and the 2009 pandemic influenza A (H1N1) in Hong Kong. The only report investigating the influence of institutional trust and public responses was published on March 27, 2019, on the Ebola outbreak in the Democratic Republic of the Congo. No previous studies have investigated how trust in the information provision and prevention instructions from the authorities during a disease outbreak has influenced the publics prevention practices and treatment-seeking in the epicenter of the 2019-nCoV.

3.
Chinese Medical Journal ; (24): 320-325, 2016.
Article in English | WPRIM (Western Pacific) | ID: wpr-310658

ABSTRACT

<p><b>BACKGROUND</b>Thalidomide is an immunomodulatory and anti-angiogenic drug that has shown promise in patients with myeloma. Trials comparing efficacy of standard melphalan and prednisone (MP) therapy with MP plus thalidomide (MPT) in transplant-ineligible or elderly patients with multiple myeloma (MM) have provided conflicting evidence. This meta-analysis aimed to determine the efficacy and toxicity of thalidomide in previously untreated elderly patients with myeloma.</p><p><b>METHODS</b>Medline, the Cochrane Controlled Trials register, conference proceedings of the American Society of Hematology (1995-2014), the American Society of Clinical Oncology (1995-2014), and CBM, VIP, and CNKI databases were searched for randomized control trials with the use of the medical subject headings "MM " and "thalidomide ". Trials were assessed by two reviewers for eligibility. Meta-analysis was conducted using a fixed effects model. Sensitivity analysis was performed to test the robustness of the findings.</p><p><b>RESULTS</b>Overall, seven trials were identified, covering a total of 1821 subjects. The summary hazard ratio (thalidomide vs. control) was 0.82 (95% confidence interval [CI]: 0.72-0.94) for overall survival (OS), and 0.65 (95% CI: 0.58-0.73) for progression-free survival, in favor of thalidomide treated group. The risk ratio of complete response with induction thalidomide was 3.48 (95% CI: 2.24-5.41). A higher rate of III/IV adverse events were observed in MPT arm compared with the MP arm. However, analysis of sub-groups administering anticoagulation as venous thromboembolism prophylaxis suggested no difference in relative risk of thrombotic events between two arms (RR = 1.47, 95% CI: 0.43-5.07, P = 0.54). Further analysis of trials on the treatment effects of MPT versus MP on adverse events-related mortality showed no statistical difference between two arms (RR = 1.24, 95% CI: [0.95-1.63], P = 0.120).</p><p><b>CONCLUSION</b>Thalidomide appears to improve the OS of elderly and/or transplant-ineligible patients with MM when it is added to standard MP therapy.</p>


Subject(s)
Humans , Disease-Free Survival , Immunosuppressive Agents , Therapeutic Uses , Melphalan , Therapeutic Uses , Multiple Myeloma , Drug Therapy , Mortality , Prednisone , Therapeutic Uses , Thalidomide , Therapeutic Uses
4.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-845865

ABSTRACT

Objective To evaluate the antimicrobial activity and establish HPLC fingerprint of flavonoids in Flos Chrysanthemi Indici. Methods Microdilution method was carried out to determine the minimum inhibitory concentration (MIC) value of total flavonoids and linarin against eleven kinds of bacteria and three fungi. HPLC fingerprint was obtained on Diamonsil C18 (4. 6 mm × 250 mm, 3 μ,m) with gradient elution consisting of acetonitrile (A) and 0. 05% phosphoric acid (B), detective wavelength was at 326 nm and flow rate 1. 0 ml/min n he room temperature. The data were analyzed by Computer Aided Similarity Evaluation software. Results MIC values of total flavonoids and inarin against Candida lusitaniae were 61. 6 μg/ml and 18. 0 μg/ml, respectively. Furthermore, fifteen characteristic peaks were indicated n fingerprint chromatography, and eight peaks were identified as flavonoids. Conclusion Total flavonoids and he inarin n Flos Chrysanthemi Indici exhibited better antimicrobial activity against C. lusitaiae. The established HPLC fingerprint method s accurate and reproducible, and can be used for the basic research and quality control of active flavonoids in Flos Chrysanthemi Indici.

SELECTION OF CITATIONS
SEARCH DETAIL
...